Real-time PCR (qPCR) Assay Market

"

Real-time PCR (qPCR) Assay Market: Current Status and Future Outlook

Real-time PCR (qPCR) assay is a molecular diagnostic technique that measures the amount of nucleic acid present in a sample. It is a powerful tool in molecular biology, genetics, and clinical diagnostics, allowing researchers and clinicians to detect and quantify specific DNA or RNA sequences in real-time. The global Real-time PCR (qPCR) assay market is expected to witness significant growth over the next few years. In this article, we will analyze the current market size, market share, key players, major trends and drivers, opportunities and threats, regulatory and legal issues, target demographics, and pricing trends of the industry.

Current Market Size and Market Share

The global Real-time PCR (qPCR) assay market is expected to grow at a CAGR of + 6.5% from 2021 to 2028, reaching ~ USD 6 billion by 2028.

The growth of the market is attributed to the increasing prevalence of infectious diseases, cancer, genetic disorders, and aging population. The COVID-19 pandemic has also significantly impacted the Real-time PCR (qPCR) assay market, as it is widely used for the diagnosis of COVID-19. the global Real-time PCR (qPCR) assay market is dominated by North America, with a market share of 36.1% in 2020, followed by Europe with a market share of 29.2%.

Key Players -

• ABL SA Group
• Agilent Technologies, Inc.
• Analytik Jena AG
• BD
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Lumex Instruments
• Primerdesign Ltd
• QIAGEN
• Takara Bio Inc
• Thermo Fisher Scientific
• TOYOBO Inc.
• Vela Diagnostics

Segmentation- 

By Product

• Reagents &Consumables
• Instruments
• Software and Services

By Application

• Clinical
• Research
• Forensics
• Others

By End User

• Hospitals &Diagnostic Centers
• Research Laboratories & Academic Institutes
• Pharmaceutical &Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

By Regional & Country Level:    

• North America

  • US.
  • Canada

• Europe

  • UK.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of the Middle East and Africa

Major Trends and Drivers Affecting the Industry

The Real-time PCR (qPCR) assay market is witnessing several major trends and drivers that are shaping the industry's growth. The increasing prevalence of infectious diseases, cancer, genetic disorders, and aging population is driving the demand for Real-time PCR (qPCR) assay. The COVID-19 pandemic has also significantly impacted the market, as Real-time PCR (qPCR) assay is widely used for the diagnosis of COVID-19. The increasing adoption of personalized medicine, advancements in technology, and increasing research and development activities are also driving the growth of the market. The rising demand for Point-of-Care (POC) testing and the increasing use of Real-time PCR (qPCR) assay in agriculture and food testing are also expected to drive the market's growth.

Opportunities and Threats in the Industry

The Real-time PCR (qPCR) assay market is witnessing several opportunities and threats. The increasing adoption of personalized medicine, the rising demand for Point-of-Care (POC) testing, and the increasing use of Real-time PCR (qPCR) assay in agriculture and food testing are some of the major opportunities in the market. However, the market is also facing several threats, such as the high cost of Real-time PCR (qPCR) assay, the availability of alternative technologies, and the lack of skilled professionals.

Regulatory and Legal Issues Affecting the Industry

The Real-time PCR (qPCR) assay market is regulated by various regulatory authorities, such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the China Food and Drug Administration (CFDA). The regulatory framework ensures the safety, efficacy, and quality of Real-time PCR (qPCR) assays. The FDA has approved several Real-time PCR (qPCR) assays for clinical use, including the Abbott RealTime SARS-CoV-2 assay, the Roche cobas SARS-CoV-2 assay, and the Thermo Fisher Scientific TaqPath COVID-19 combo kit. The regulatory and legal issues affecting the industry are likely to change in the future with the introduction of new regulations and guidelines.

Target Demographics and Preferences

The Real-time PCR (qPCR) assay market targets several demographics, including researchers, clinicians, and laboratories. Researchers and clinicians use Real-time PCR (qPCR) assays for molecular biology, genetics, and clinical diagnostics, while laboratories use it for testing samples for infectious diseases, cancer, and genetic disorders. The target demographics' preferences and behaviors are focused on accuracy, speed, and reliability of Real-time PCR (qPCR) assays, as well as ease of use and cost-effectiveness.

Pricing Trends in the Industry

The pricing trends in the Real-time PCR (qPCR) assay market vary across different segments, such as instruments, reagents, and software. The instruments segment dominates the market and is expected to grow at a CAGR of 6.2% from 2021 to 2028. The pricing of instruments is relatively higher than reagents and software, as it involves the purchase of expensive equipment. The reagents segment is expected to grow at a CAGR of 6.6% from 2021 to 2028, as it is an essential component of Real-time PCR (qPCR) assay. The pricing of reagents is relatively lower than instruments, but it is subject to price fluctuations due to the availability of raw materials and competition among players.

Conclusion

In conclusion, the global Real-time PCR (qPCR) assay market is expected to witness significant growth over the next few years, driven by the increasing prevalence of infectious diseases, cancer, genetic disorders, and aging population. The COVID-19 pandemic has also significantly impacted the market. The market is highly competitive and fragmented, with several players operating in the market. The major trends and drivers affecting the industry are the increasing adoption of personalized medicine, advancements in technology, and increasing research and development activities. The market is facing several opportunities and threats, such as the rising demand for Point-of-Care (POC) testing and the availability of alternative technologies. The regulatory and legal issues affecting the industry are likely to change in the future. The Real-time PCR (qPCR) assay market targets several demographics, including researchers, clinicians, and laboratories, with preferences and behaviors focused on accuracy, speed, and reliability of Real-time PCR (qPCR) assays, as well as ease of use and cost-effectiveness. The pricing trends in the industry vary across different segments, such as instruments, reagents, and software.

"